This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Fortrea's CTO discusses AI's expanding role in clinical trials, from discovery t...
Review of transparency rules for the EU Clinical Trials Information System (CTIS)
Venture capital firm Kineticos Life Sciences has launched a new biotech to take ...
Generic drugmaker Stada is preparing for what could be Europe’s biggest IPO this...
European Medicines Agency procedural advice for users of the centralised procedu...
European Medicines Agency procedural advice for users of the centralised procedu...
Marketing authorisation application (MAA) - pre-submission interactions form
Human medicines European public assessment report (EPAR): Xeljanz, tofacitinib, ...
European Medicines Agency pre-authorisation procedural advice for users of the c...
European Medicines Agency pre-authorisation procedural advice for users of the c...
Human medicines European public assessment report (EPAR): Neparvis, sacubitril,v...
Human medicines European public assessment report (EPAR): Entresto, sacubitril,v...
Early-phase clinical trials, including phase 1 and some phase 2a studies, serve ...
Orphan designation: Adeno-associated virus serotype 9 containing the human RPE65...
Human medicines European public assessment report (EPAR): Avastin, bevacizumab, ...
Orphan designation: N-(4-(4-amino-5-(3-fluoro-4-((4-methylpyrimidin-2-yl)oxy)phe...
Orphan designation: Arsenic trioxide Treatment of acute promyelocytic leukaemia,...
Fueled by pandemic frustrations, populist parties are embracing anti-vaccine fig...
A small study on Covid vaccine safety has sparked an online tempest — and highli...
If the Trump administration truly wants to reduce waste and fraud in government ...